Cancer Therapy with Nanoparticle-Medicated Intracellular Expression of Peptide CRM1-Inhibitor
Sui Min(Sichuan University), Qingxiang Sun(University of Electronic Science and Technology of China), Maling Gou(Sichuan University), Meimei Xiong(Sichuan University), Xiaofei Shen(Sichuan University), Da Jia(Sichuan University), Yuling Li(Jiangsu Normal University), Qiao Zhou(Commercial Aircraft Corporation of China (China))
Cited by 8
Related Papers
Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia
|Blood|2012|300
Structural Basis for the Inhibition Mechanism of Human Cystathionine γ-Lyase, an Enzyme Responsible for the Production of H2S
|Journal of Biological Chemistry|2008|206
BCL-xL Is a Target Gene Regulated by Hypoxia-inducible Factor-1α
|Journal of Biological Chemistry|2009|197
Nuclear export inhibition through covalent conjugation and hydrolysis of Leptomycin B by CRM1
|Proceedings of the National Academy of Sciences|2013|196